| abstract |
In Formula I quinoxaline and quinoxalkylalkone-phosphonic acids (formula), R1 is independently or esterified carboxy or independently or partially esterified phosphono, R2 and R3 independently of one another are hydrogen, aliphatic hydrocarbon root, independently or etherized hydroxy, independently or etherized orer oxidized independently or etherized mercapto, unaltered or aliphatically modified amino, nitro, independent or amidated sulfamoyl, halogen or trifluoromethyl and X is a double-valued aliphatic root; and its tautomers and / or salts have NMDA-digestion properties and can be used in the treatment of pathological conditions that respond to the inhibition of NMDA-sensitive receptors. |